InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Haas Kevin Richard, Chief Technology Officer. Director active across 1 companies, notably Myriad Genetics INC. Cumulatively, 11 disclosures have been published. The latest transaction was disclosed on 24 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
€26,5251,153 shares@ €23.0050.0078% mcap15.9% of flow
Common Stock
SEC:0001843872-22-000008:0·
019,238 shares0
Common Stock
SEC:0001843872-22-000006:0·
€19,084865 shares@ €22.0630.0056% mcap11.5% of flow
Common Stock
SEC:0001843872-22-000004:0·
019,520 shares0
Common Stock
SEC:0001843872-22-000002·
019,520 shares0
Common Stock
SEC:0001843872-22-000002:0·
€46,1871,729 shares@ €26.71340.014% mcap76.4% of flow
Common Stock
SEC:0001843872-21-000015·
€46,1871,729 shares@ €26.71340.014% mcap27.7% of flow
Common Stock
SEC:0001843872-21-000015:0·
€9,817346 shares@ €28.37250.0029% mcap16.2% of flow
Common Stock
SEC:0001843872-21-000013·
€9,817346 shares@ €28.37250.0029% mcap5.9% of flow
Common Stock
SEC:0001843872-21-000013:0·
€4,475344 shares@ €13.00810.0013% mcap7.4% of flow
Common Stock
SEC:0001843872-21-000011·
€4,475344 shares@ €13.00810.0013% mcap2.7% of flow
Common Stock
SEC:0001843872-21-000011:0·
11 of 11 declarations
About Haas Kevin Richard
Kevin Richard Haas is the Chief Technology Officer at MYRIAD GENETICS INC. He is responsible for the technology strategy and innovation within the company. His role involves leading the development of technological solutions and ensuring that technology supports business objectives.
